ArticleJournal of the American College of Cardiology2019

Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics.

Carlos G Santos-Gallego et al.PubMed ↗Publisher ↗

No numbers read from the abstract.